Lupus & antiphospholipid syndrome

Assessment of renal response in Tunisian patients with proliferative lupus nephritis under three different induction immunosuppressive agents: A prognostic retrospective study

LupusPublished Retrospective cohort study

Main finding · Renal responseResult — go to the resultAdjusted odds ratio 9.846 95% CI 1.087–98.210

Authors' conclusion

As an induction treatment for PLN, the High CYP regimen was strongly associated with a higher rate of RR than the MMF regimen. There were no statistically significant differences between the High CYP regimen and the Low CYP regimen in terms of RR.

Study context

Population
Kidney biopsy proven proliferative LN patients, Internal Medicine Department, Habib Thameur University Hospital, Tunis, 2000–2023
Participants
78 patients
Exposure
High cyclophosphamide (CYP) vs Low CYP vs MMF induction regimens
  • High CYPn = 17
  • Low CYPn = 40
  • MMFn = 21reference
Outcome
Incidence of renal response (complete and partial remission)
Follow-up
One year post-diagnosis
Methodological detailsprognostic, single-centre
  • Prognostic
  • Single-centre

Main finding

Renal response

Adjusted odds ratio

9.846

95% CI 1.087–98.210

P = 0.042

By group

High CYPvs MMF
aOR 9.846 (95% CI 1.087–98.210); P = 0.042

As reported in the abstract

Observational data: associations, not effects.

Further findings

Events

OutcomeLow CYPMMF
ESKD3— not stated in the abstract
Death41

— not stated in the abstract

Death — Total deaths
5

End-stage kidney disease (ESKD)

3 cases of ESKD, all in the Low CYP group

Safety

Events

OutcomeHigh CYPLow CYPMMF
Severe AEs (all severe infections)5123
  • Severe adverse events (AEs) (all severe infections): 20 cases of severe AEs

Original publication

Assessment of renal response in Tunisian patients with proliferative lupus nephritis under three different induction immunosuppressive agents: A prognostic retrospective study. Lupus. Published 3 October 2024. doi:10.1177/09612033241289479

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.